Breaking News Instant updates and real-time market news.

TWTR

Twitter

$17.56

-2.29 (-11.54%)

, BAC

Bank of America

$16.30

0.17 (1.05%)

08:55
10/11/16
10/11
08:55
10/11/16
08:55

Notable open interest changes for October 11th

Monday's total option volume of 11.9 million contracts resulted in net open interest growth of 2.15 million calls and 1.87 million puts. Twitter (TWTR), Bank of America (BAC), Apple (AAPL) and Bristol Myers Squibb (BMY) saw the greatest growth. Top five new positions opened include 39k Bank of America (BAC) Dec-16 16 calls, 31k Wells Fargo (WFC) Nov-16 40 puts, 30k Bank of America (BAC) Jan-17 22 puts, 27k Bank of America (BAC) Jan-17 22 calls and 23k Weatherford (WFT) Dec-16 7 calls.

TWTR

Twitter

$17.56

-2.29 (-11.54%)

BAC

Bank of America

$16.30

0.17 (1.05%)

AAPL

Apple

$116.05

1.99 (1.74%)

BMY

Bristol-Myers

$49.81

-5.62 (-10.14%)

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 31

    Oct

  • 06

    Nov

  • 30

    Nov

  • 13

    Mar

TWTR Twitter
$17.56

-2.29 (-11.54%)

10/07/16
ADAM
10/07/16
NO CHANGE
Target $95
ADAM
Buy
Salesforce worthy of investor consideration at current levels, says Canaccord
Canaccord analyst Richard Davis came away from the Salesforce (CRM) Dreamforce week more enthused about the company's outlook. The analyst noted the company is growing its revenues 3.5 times faster than it legacy peers. Davis noted the company's CEO said they are very disciplined on price when it comes to acquisitions and believes that they would not be interested in Twitter (TWTR) at its rumored asking price of $28 per share. Davis reiterated his Buy rating and $95 price target on Salesforce shares.
10/11/16
DBAB
10/11/16
NO CHANGE
Target $22
DBAB
Buy
Twitter guidance could meet, exceed estimates, says Deutsche Bank
Deutsche Bank analyst Ross Sandler says that for the first time in a year, Twitter's guidance could meet or exceed consensus expectations. The analyst sees a good risk/reward profile for shares into the company's Q3 results. He notes that his channel checks point to a "high-end of the range" revenue with "slightly up" monthly active users for Q3. Twitter's NFL live video project "has been by all accounts a smashing success," Sandler tells investors in a research note. He keep a Buy rating on Twitter with a $22 price target.
10/11/16
EVER
10/11/16
UPGRADE
Target $17
EVER
Hold
Twitter upgraded to Hold from Sell at Evercore ISI
Evercore ISI analyst Ken Sena upgraded Twitter (TWTR) to Neutral citing the recent pullback in the shares. The analyst notes that the selloff "from a stalled sale process" has put the stock more in-line with his unchanged price target of $17. Sena thinks Twitter's guidance for Q3 "may prove sufficiently conservative."
10/10/16
JPMS
10/10/16
NO CHANGE
Target $95
JPMS
Overweight
JPMorgan sees 'opportune entry point' for Salesforce
JPMorgan analyst Mark Murphy believes shares of Salesforce (CRM) are at an "'opportune entry point" following the recent selloff. The pullback has been driven by a "slightly soft" Q2 and concerns about a potentially expensive acquisition of Twitter (TWTR), Murphy tells investors in a research note. After speaking to industry contacts at Dreamforce, the analyst sees a path for the "overhangs to fade" with a "better pace of business in Q3/Q4" as well as the eventual fading of the Twitter discussion. Murphy reiterates an Overweight rating on Salesforce with a $95 price target in a research note titled "The Most Valuable Cloud Asset Is Undeservedly Undervalued."
BAC Bank of America
$16.30

0.17 (1.05%)

10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Oppenheimer technical analyst upgrades Financials, downgrades Consumer Staples
Oppenheimer technical analyst Ari Wald upgraded the Financials sector to Market Weight and downgraded Consumer Staples to Underweight in next step in the firm's "cyclical rotation road map." Wald identified Ameriprise (AMP), Bank of America (BAC), Citi (C), Goldman Sachs (GS), Lincoln National (LNC) and SunTrust (STI) as six stocks breaking higher that he sees as likely to benefit from internal market rotation.
09/13/16
SOCG
09/13/16
DOWNGRADE
Target $42
SOCG
Sell
Societe Generale cuts Citi to Sell, Bank of America to Hold
Societe Generale downgraded Citi (C) to Sell from Hold and Bank of America (BAC) to Hold from Buy. The firm has a $42 price target for shares of Citi and attributes an increased negative stance on Cards for the downgrade. Societe Generale has a $17 price target for Bank of America and cites revenue growth for the downgrade to Hold. Citi is trading down 86c to $46.93 and Bank of America is trading down 19c to $15.71.
09/16/16
GSCO
09/16/16
NO CHANGE
Target $19
GSCO
Conviction Sell
Bank of America operating leverage hitting an inflection, says Goldman
Goldman analyst Richard Ramsden believes Bank of America is hitting an inflection point in operating leverage driven by low single digit growth, stable credit, and absolute reductions in the expense base. The analyst believes topline growth will reach approximately 4% annually through to 2018, driven by consumer bank and wealth management initiatives. Ramsden reiterates his Conviction Buy rating on Bank of American and raised his price target to $19 from $17 given the combination of revenue growth and expense discipline.
10/11/16
COMP
10/11/16
INITIATION
Target $13
COMP
Neutral
Bank of America initiated with a Neutral at Compass Point
Compass Point analyst Charles Peabody initiated Bank of America with a Neutral and a $13 price target.
AAPL Apple
$116.05

1.99 (1.74%)

10/10/16
DBAB
10/10/16
INITIATION
Target $90
DBAB
Sell
Deutsche sees Netflix takeover as unlikely, starts shares at Sell
Deutsche Bank analyst Bryan Kraft initiated shares of Netflix (NFLX) with a Sell rating and $90 price target. The stock closed Friday down 25c to $104.82. The risk/reward is unattractive as consensus expectations reflect an "optimistic case," Kraft tells investors in a research note. Market expectations appear too high through 2020, the analyst contends. He also expresses skepticism that Netflix will be acquired. The business is "too fully formed" and valued to be acquired by Disney (DIS) and Apple (AAPL), Kraft writes. He also sees Amazon.com (AMZN) as a competitive risk to Netflix.
10/07/16
RBCM
10/07/16
NO CHANGE
RBCM
Apple average selling prices could beat expectations, says RBC Capital
RBC Capital analyst Amit Daryanani says that his analysis indicates that the average selling prices of Apple's iPhone 7 could significantly exceed Street expectations. Stronger demand for the "plus" model versus the last two years, along with the fact that Apple is charging a $120 premium for the "plus" model versus a $100 premium historically, should boost average selling prices, the analyst stated. He thinks that Apple's September quarter revenue could beat expectations by a "modest" amount, while the company's December quarter guidance could be "materially ahead of Street expectations." He keeps a $125 price target and Outperform rating on the stock.
10/06/16
RBCM
10/06/16
NO CHANGE
RBCM
Apple has positive read through from Dialog results, says RBC Capital
After Dialog issued a positive preannouncement due to higher than expected Mobile Services revenue, RBC Capital analyst Amit Daryanani thinks that the Dialog results should comfort Apple investors heading into that company's September quarter results. The analyst notes that Apple accounts for 75%-80% of Dialog's revenue. He keeps a $125 price target and Outperform rating on Apple.
10/06/16
ADAM
10/06/16
NO CHANGE
Target $140
ADAM
Buy
Apple iPhone 7 demand remains healthy, says Canaccord
Canaccord analyst T. Michael Walkley said channel checks show demand for iPhone 7 remains healthy with an ongoing strong mix leading to higher selling prices. The analyst believes the iPhone 6 and iPhone 6s products enabled Apple to materially increase its market share and installed base of the premium tier smartphone market. Walkley reiterate his Buy rating and $140 price target on Apple shares.
BMY Bristol-Myers
$49.81

-5.62 (-10.14%)

09/20/16
SBSH
09/20/16
NO CHANGE
Target $70
SBSH
Buy
Bristol-Myers price target lowered to $70 from $75 at Citi
In a research note titled "Brace Yourself. Attractive Valuation but No Near-Term Respite.," Citi analyst Andrew Baum lowered his price target for shares of Bristol-Myers Squibb to $70 from $75. The analyst lowered his earnings forecasts by up to 8% to reflect the "limited supportive data" in the non-small cell lung cancer indication. Baum keeps a Buy rating on the shares as he views the valuation as attractive. He points out, however, the near-term news-flow is likely to be negative.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.
09/28/16
ROTH
09/28/16
NO CHANGE
Target $23
ROTH
Buy
Nektar price target raised to $23 from $19 at Roth Capital
Roth Capital analyst Michael Higgins raised his price target for Nektar (NKTR) to $23 from $19 after the company and Bristol-Myers (BMY) announced a clinical collaboration to evaluate the combination of the latter's anti-PD-1 antibody, Opdivo, with NKTR-214. The analyst reiterates a Buy rating on Nektar's shares.
10/10/16
LEER
10/10/16
NO CHANGE
LEER
Outperform
Leerink sees Bristol-Myers sliding after Merck's 'spectacular' Keytruda data
Leerink analyst Seamus Fernandez said Bristol-Myers' (BMY) Checkmate-026 data presented at the European Society of Medical Oncology meeting was disappointing, noting there was no signal of benefit on progression-free survival or overall survival and only "modest differentiation" on response rate in the 88 patients with PDL1 biomarker positivity greater than or equal to 50%. Meanwhile, Merck (MRK) presented "spectacular" data for Keytruda monotherapy at the meeting, said Fernandez, who expects Bristol shares to be down "significantly" today in light of the meeting presentations. The analyst, who still thinks Bristol has a significant opportunity to compete with Merck's Keytruda in the PDL1 high portion of the market, keeps an Outperform rating on Bristol shares, which are down nearly 6% in pre-market trading.

TODAY'S FREE FLY STORIES

P

Pandora

$13.22

-0.36 (-2.65%)

11:51
02/21/17
02/21
11:51
02/21/17
11:51
Periodicals
Pandora looks to country music to boost subscription aspirations, WSJ says »

Internet radio giant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 28

    Feb

  • 19

    Mar

GPC

Genuine Parts

$98.26

-2.41 (-2.39%)

11:49
02/21/17
02/21
11:49
02/21/17
11:49
Hot Stocks
Breaking Hot Stocks news story on Genuine Parts »

Genuine Parts says has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TRVN

Trevena

$7.13

0.1 (1.42%)

11:47
02/21/17
02/21
11:47
02/21/17
11:47
Recommendations
Trevena analyst commentary  »

Jefferies sees hospital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 21

    Mar

PRGO

Perrigo

$84.36

-0.11 (-0.13%)

11:46
02/21/17
02/21
11:46
02/21/17
11:46
Hot Stocks
Perrigo raises dividend to 16c from 14.5c per share »

Perrigo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 21

    Mar

GPC

Genuine Parts

$98.41

-2.26 (-2.25%)

11:46
02/21/17
02/21
11:46
02/21/17
11:46
Hot Stocks
Breaking Hot Stocks news story on Genuine Parts »

Genuine Parts says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AMAT

Applied Materials

$35.67

0.49 (1.39%)

11:46
02/21/17
02/21
11:46
02/21/17
11:46
Options
Applied Materials call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

DISCA

Discovery

$28.68

0.11 (0.39%)

11:45
02/21/17
02/21
11:45
02/21/17
11:45
Conference/Events
Discovery management to meet with Jefferies »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

11:45
02/21/17
02/21
11:45
02/21/17
11:45
General news
Breaking General news story  »

Philadelphia Federal…

EFX

Equifax

$129.38

-0.76 (-0.58%)

11:42
02/21/17
02/21
11:42
02/21/17
11:42
Conference/Events
Equifax to hold a webcast »

Equifax Senior Vice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$98.46

-2.2124 (-2.20%)

11:41
02/21/17
02/21
11:41
02/21/17
11:41
Hot Stocks
Breaking Hot Stocks news story on Genuine Parts »

Genuine Parts says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MDLZ

Mondelez

$42.50

-0.7 (-1.62%)

, KHC

Kraft Heinz

$96.65

9.37 (10.74%)

11:38
02/21/17
02/21
11:38
02/21/17
11:38
Hot Stocks
Mondelez takeover speculation lifts shares as Kraft walks from Unilever »

Shares of Mondelez (MDLZ)…

MDLZ

Mondelez

$42.50

-0.7 (-1.62%)

KHC

Kraft Heinz

$96.65

9.37 (10.74%)

UL

Unilever; also tag UN

$44.54

-3.99 (-8.22%)

UN

Unilever; also tag UL

$44.77

-4.025 (-8.25%)

BRK.A

Berkshire Hathaway

$254,021.52

1183.52 (0.47%)

BRK.B

Berkshire Hathaway

$169.35

0.78 (0.46%)

GIS

General Mills

$60.68

1.45 (2.45%)

K

Kellogg

$74.17

1.27 (1.74%)

CPB

Campbell Soup

$58.60

0.12 (0.21%)

CL

Colgate-Palmolive

$73.15

1.17 (1.63%)

KMB

Kimberly-Clark

$133.18

1.25 (0.95%)

CLX

Clorox

$134.98

1.27 (0.95%)

HSY

Hershey

$108.33

1.08 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

  • 19

    Mar

11:38
02/21/17
02/21
11:38
02/21/17
11:38
General news
6-Month Bill Auction Bid/Cover data reported »

6-Month Bill Auction…

11:38
02/21/17
02/21
11:38
02/21/17
11:38
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:37
02/21/17
02/21
11:37
02/21/17
11:37
General news
3-Month Bill Auction Bid/Cover data reported »

3-Month Bill Auction…

11:37
02/21/17
02/21
11:37
02/21/17
11:37
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

PLKI

Popeyes

$66.12

-0.26 (-0.39%)

, QSR

Restaurant Brands

$57.55

3.65 (6.77%)

11:36
02/21/17
02/21
11:36
02/21/17
11:36
Downgrade
Popeyes, Restaurant Brands rating change  »

Popeyes downgraded to…

PLKI

Popeyes

$66.12

-0.26 (-0.39%)

QSR

Restaurant Brands

$57.55

3.65 (6.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 23

    Mar

HLF

Herbalife

$61.22

-0.01 (-0.02%)

11:36
02/21/17
02/21
11:36
02/21/17
11:36
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

GPC

Genuine Parts

$99.10

-1.57 (-1.56%)

11:32
02/21/17
02/21
11:32
02/21/17
11:32
Hot Stocks
Genuine Parts sees FY17 automotive, industrial sales up 3%-4% »

Says U.S. sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

11:30
02/21/17
02/21
11:30
02/21/17
11:30
General news
The Bund/T-note spread continued to widen to -212 bp »

The Bund/T-note spread…

FCH

Felcor Lodging

$7.89

0.66 (9.13%)

, AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

11:27
02/21/17
02/21
11:27
02/21/17
11:27
Hot Stocks
Breaking Hot Stocks news story on Felcor Lodging, Ashford Hospitality »

Felcor: Company, Ashford…

FCH

Felcor Lodging

$7.89

0.66 (9.13%)

AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 24

    Feb

FCH

Felcor Lodging

$7.89

0.66 (9.13%)

, AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

11:26
02/21/17
02/21
11:26
02/21/17
11:26
Hot Stocks
Breaking Hot Stocks news story on Felcor Lodging, Ashford Hospitality »

Felcor Lodging says has…

FCH

Felcor Lodging

$7.89

0.66 (9.13%)

AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 24

    Feb

COP

ConocoPhillips

$48.37

0.86 (1.81%)

11:26
02/21/17
02/21
11:26
02/21/17
11:26
Options
ConocoPhillips call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

FCH

Felcor Lodging

$7.87

0.64 (8.85%)

, AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

11:25
02/21/17
02/21
11:25
02/21/17
11:25
Hot Stocks
Felcor Lodging confirms unsolicited offer from Ashford Hospitality »

FelCor Lodging Trust…

FCH

Felcor Lodging

$7.87

0.64 (8.85%)

AHT

Ashford Hospitality

$7.61

-0.04 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 24

    Feb

11:25
02/21/17
02/21
11:25
02/21/17
11:25
Conference/Events
CFA Society of Philadelphia to hold a luncheon meeting »

Luncheon Meeting where…

11:25
02/21/17
02/21
11:25
02/21/17
11:25
Conference/Events
Federal Reserve Bank of Philadelphia President speaks on economic outlook »

Philadelphia Federal…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.